The Body As A Bioreactor – The Vision

Cell therapy has delivered remarkable scientific advances, yet its reliance on complex, ex vivo manufacturing has created a bottleneck that limits scale, speed, and patient reach. A new way of thinking is emerging—one that treats the human body itself as the manufacturing site. This perspective reframes therapy from something built outside the patient to something enabled within them. By shifting from external cell engineering to in vivo delivery of molecular instructions, therapies can be produced where they are needed, when they are needed. This approach blends the strengths of established cell therapies with the flexibility of in vivo modalities, opening a path toward broader access and more sustainable global deployment.

Watch to see how this shift could redefine how advanced therapies are developed, delivered, and shared worldwide.